Study on circadian variation in folate pharmacokinetics

Canadian Journal of Clinical Pharmacology

Volumn 12, Issue 1, 2005, Pages

  Ahn, Eric ^a,b   Kapur, Bhushan ^a,b   Koren, Gideon ^a,b  

^a HOSPITAL FOR SICK CHILDREN   (Canada)

^b UNIVERSITY OF TORONTO   (Canada)

Author keywords

Bioavailability; Circadian rhythm; Folate; Multivitamins; PregVit ; Prenatal

Indexed keywords

FOLIC ACID; PREGVIT;

ADULT; AREA UNDER THE CURVE; ARTICLE; CIRCADIAN RHYTHM; CONTROLLED STUDY; DRUG ADSORPTION; FEMALE; FOLIC ACID BLOOD LEVEL; HUMAN; HUMAN EXPERIMENT; NORMAL HUMAN;

EID: 18844460484     PISSN: 1198581X     EISSN: 17106222     Source Type: Journal    
DOI: None     Document Type: Article

References (25)

1. Czeizel AE, Dudas I. Prevention of the first occurrence of neural-tube defects by periconceptional vitamin supplementation. N Engl J Med 1992; 327(26):1832-1835.
2. MRC Vitamin Study Research Group. Prevention of neural tube defects: results of the Medical Research Council Vitamin Study. Lancet 1991; 338(8760):131-137.
3. Shaw GM, O'Malley CD, Wasserman CR, Tolarova MM, Lammer EJ. Maternal periconceptional use of multivitamins and reduced risk for conotruncal heart defects and limb deficiencies among offspring. Am J Med Genet 1995; 59(4):536-545.
4. Czeizel AE. Prevention of congenital abnormalities by periconceptional multivitamin supplementation. BMJ 1993; 306(6893):1645-1648.
5. Czeizel AE. Reduction of urinary tract and cardiovascular defects by periconceptional multivitamin supplementation. Am J Med Genet 1996; 62(2):179-183.
6. Botto LD, Khoury MJ, Mulinare J, Erickson JD. Periconceptional multivitamin use and the occurrence of conotruncal heart defects: results from a population-based, case-control study. Pediatrics 1996; 98(5):911-917.
7. Li DK, Daling JR, Mueller BA, Hickok DE, Fantel AG, Weiss NS. Periconceptional multivitamin use in relation to the risk of congenital urinary tract anomalies. Epidemiol 1995; 6(3):212-218.
8. Shaw GM, Lammer EJ, Wasserman CR, O'Malley CD, Tolarova MM. Risks of orofacial clefts in children born to women using multivitamins containing folic acid periconceptionally. Lancet 1995; 346(8972):393-396.
9. Wilson RD, Davies G, Desilets V, Reid GJ, Summers A, Wyatt P et al. The use of folic acid for the prevention of neural tube defects and other congenital anomalies. JOGC 2003; 25(11):959-965.
10. Wald NJ. Folic acid and the prevention of neural-tube defects. N Engl J Med 2004; 350(2):101-103.
11. Wald NJ, Law MR, Morris JK, Wald DS. Quantifying the effect of folic acid. Lancet 2001; 358(9298):2069-2073.
12. Campbell NR, Hasinoff BB. Iron supplements: a common cause of drug interactions. Br J Clin Pharmacol 1991; 31(3):251-255.
13. Ghishan FK, Said HM, Wilson PC, Murrell JE, Greene HL. Intestinal transport of zinc and folic acid: a mutual inhibitory effect. Am J Clin Nutr 1986; 43(2):258-262.
14. Koren G, Boskovic R, Hard M, Maltepe C, Navioz Y, Einarson A. Motherisk-PUQE (pregnancy-unique quantification of emesis and nausea) scoring system for nausea and vomiting of pregnancy. Am J Obstet Gynecol 2002; 186(5 Suppl Understanding):S228-S331.
15. Ahn E, Koren G. The Effects of Nausea and Vomiting of Pregnancy on Compliance with Materna. Can.J.Clin.Pharmacol. 2003; 10(3):150 (Abstract).
16. Lemmer B. Chronopharmacokinetics: implications for drug treatment. J Pharm Pharmacol 1999; 51(8):887-890.
17. Labrecque G, Belanger PM. Biological rhythms in the absorption, distribution, metabolism and excretion of drugs. Pharmacol Ther 1991; 52(1):95-107.
18. Braguerolle B. Chronopharmacokinetics. Current status. Clin Pharmacokinet 1998; 35(2):83-94.
19. Wegner C, Nau H. Diurnal variation of folate concentrations in mouse embryo and plasma: the protective effect of folinic acid on valproic-acid- induced teratogenicity is time dependent. Reprod Toxicol 1991; 5(6):465-471.
20. Bothwell TH, Conrad ME, Cook JD, Finch CA. Iron Metabolism in Man. Oxford: Blackwell Scientific Publications, 1979.
21. Rowland M, Tozer T. Clinical pharmacokinetics: concepts and applications. 3rd ed. ed. Baltimore: Williams & Wilkins, 1995.
22. Dawson EB, Evans DR, Conway ME, McGanity WJ. Vitamin B12 and folate bioavailability from two prenatal multivitamin/multimineral supplements. Am J Perinatol 2000; 17(4):193-199.
23. Sifakis S, Pharmakides G. Anemia in Pregnancy. Ann N Y Acad Sci 2000; 900:125-136.
24. Galloway R, McGuire J. Determinants of compliance with iron supplementation: supplies, side effects, or psychology? Soc Sci Med 1994; 39(3):381-390.
25. Alward N, Kevany J. Iron Supplementation During Pregnancy: A Survey of the Current Situation. Ir J Med 1984; 77(4):112-114.